New CBD companies are finding it difficult to enter retail channels.
APHA's strategy is to perfect operations in Canada so that they'll be ready when cannabis is legalized in the U.S.
Anyone playing the guessing game into earnings is rolling the dice.
Altria has future growth potential, over 50 years of dividend increases and a high yield exceeding 8%.
CGC has started to make its move to the upside, so let's see what the charts say and how to play this cannabis name.
Investors are anxious to grab the next penny stock that may be poised to jump on the mind-blowing bubble. Here they are.
A messy situation hangs over a state that could rival Colorado or Illinois for sales.
It's a mistake to declare the action as either bullish or bearish.
How is Trulieve accomplishing what so many other cannabis companies have attempted and failed?
My focus remains on individual stock picking. The market timers are being crushed again.
The daily picture has my attention. The big watch here is the 50-day simple moving average.
There are 153,000 convenience stores in the U.S. and these outlets sell the bulk of the country's cigarettes.
Here's our latest trading strategy on STZ.
Experts predict it could take 12-18 months for the market to recover.
After finding success in treatment for epilepsy and other conditions, some in the industry are focusing on autism spectrum disorder.
Here's how investors can trade the cannabis stock.
This six-pack from investment specialists includes a REIT and a software provider specializing in the industry.
Mydecine Innovations Group -- formerly known as NewLeaf -- signed an agreement with the University of Alberta's Faculty of Pharmacy and Pharmaceutical Sciences.
Not many marijuana stocks pay dividends, so income investors have a unique opportunity with this REIT.
With over $2.5 billion raised by SPACs in the cannabis industry, there is more buying power in the market that is fueling new M&A activity.
The cannabis name is budding into a serious contender in the industry -- and is catching the eyes of impressed analysts.
Put CGC on your potential shopping list and let's keep an eye on it.
The quick return to cannabis dispensaries shows that the demise of brick and mortar is a myth.
Despite the lackluster action there are some pockets of good stock picking again.
That doesn't mean we'll move straight up over the summer, but we'll get plenty of virus, China, stimulus, cannabis, and unemployment chatter.
One notable area of trading on Thursday was the pot stocks, and I expect to see that continue as speculative traders look for some 'holiday' trading.
State's dispensaries get OK to reopen recreational curbside service on May 25.
Time to go long?
Political games of smoke and mirrors are making Asian trades look risky, but there may be another opportunity sprouting up.
Still, Covid has forced attention on company balance sheets and a hard look at cash burn rates and investment choices.